Skip to main content
. 2020 Apr 30;7(12):2000173. doi: 10.1002/advs.202000173

Figure 7.

Figure 7

Summary of relative ECM compositions as deposited in de novo grown tissues in response to different flow regimes, as well as in the presence of the MMP inhibitor doxycycline, a drug that is clinically used to treat aneurysm and atherosclerosis plaques. In the upper part, the top views of the curved engineered tissues attached to the edge of the device platform are shown.